HRT can also be a concern after treatment. If you’ve been treated for HR+ breast cancer, “There is always some small risk ...

Adjuvant therapy may include radiation therapy and some combination of chemotherapy, hormone therapy, and/or targeted therapy. Tamoxifen has been approved by the FDA for adjuvant hormone treatment of ...

Aromatase inhibitors (AIs) are a cornerstone of adjuvant therapy for hormone receptor–positive breast cancer, significantly reducing recurrence and mortality. However, by suppressing estrogen ...

Cancer cells can evolve to grow independently of hormone signals, necessitating treatment reassessment. Estrogen receptor-positive cells require estrogen, while HER2-negative cells have minimal HER2 ...

Geospatial Genomics: Operationalizing Multilevel Conceptual Frameworks of Cancer Health Outcomes to Account for Gene-Person-Place Relationships At the time of the primary PFS analysis, interim ...

Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2–Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase ...

QIMR Berghofer scientists have discovered a cancer-fighting RNA molecule that could hold the key to a new way of treating the ...

For decades, doctors have been puzzled by why women develop Alzheimer’s disease at nearly twice the rate of men. There are an estimated 7 million people in the U.S. living with Alzheimer’s, with that ...

In this phase 3 study, researchers sought to determine whether the addition of palbociclib may overcome resistance to endocrine and HER2-directed therapies.

Faslodex (fulvestrant) is a prescription medicine used for people with certain types of breast cancer. Faslodex is given as an injection into the buttocks (gluteal area) by a health care provider in a ...

Progesterone Receptor Positive (PR+) breast cancer is a distinct biological subtype of hormone receptor positive breast cancer. This type of cancer grows in response to progesterone, a hormone that is ...